|
ADAM17 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.251600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.610800E-01 |
| Normal-vs-Stage2 |
2.486000E-01 |
| Normal-vs-Stage3 |
9.531600E-02 |
| Normal-vs-Stage4 |
5.951700E-02 |
| Stage1-vs-Stage2 |
5.289200E-01 |
| Stage1-vs-Stage3 |
1.665590E-01 |
| Stage1-vs-Stage4 |
1.806810E-01 |
| Stage2-vs-Stage3 |
7.177200E-01 |
| Stage2-vs-Stage4 |
5.730400E-01 |
| Stage3-vs-Stage4 |
8.125600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.942400E-01 |
| Normal-vs-AfricanAmerican |
4.858600E-01 |
| Normal-vs-Asian |
3.483600E-01 |
| Caucasian-vs-AfricanAmerican |
1.499390E-01 |
| Caucasian-vs-Asian |
9.550800E-01 |
| AfricanAmerican-vs-Asian |
1.696170E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.461800E-01 |
| Normal-vs-Female |
2.406800E-01 |
| Male-vs-Female |
8.709000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.099800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.790770E-01 |
| Normal-vs-Age(61-80Yrs) |
3.423500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.125800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.872220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.093500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.486200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.426600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.902800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.318600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.246300E-02 |
| Classical-VS-Follicular |
6.179100E-04 |
| Classical-VS-Other |
2.319800E-01 |
| Classical-VS-Normal |
8.901200E-01 |
| Tall-VS-Follicular |
8.409600E-01 |
| Tall-VS-Other |
8.721600E-01 |
| Tall-VS-Normal |
4.720400E-02 |
| Follicular-VS-Other |
9.697800E-01 |
| Follicular-VS-Normal |
1.181900E-02 |
| Other-VS-Normal |
1.895770E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.976000E-02 |
| Normal-vs-N1 |
9.951900E-02 |
| N0-vs-N1 |
8.668200E-01 |
|
|
